Cancer drug development is the most complex challenge faced by the drug industry today, with clinical trials being the most technically difficult, time consuming and expensive aspect of the process.

Recruiting patients, monitoring sites and analysing complex data can be daunting for cost-sensitive pharmas, which is why more and more turn to CROs with oncology expertise to help tap the lucrative cancer therapeutics market.

The Oncology Trials Outsourcing conference will examine the contract oncology research sector: the strategies that work and those that don’t; the path to success and hurdles to avoid, with expert opinion and industry insight.

We’ll also look to the future and discuss the emerging trends and hot topics, from adaptive protocols to personalized medicines that will be critical to success for pharmas seeking to create the next generation of treatments.